Abstract
Two copolymers are designed and synthesised for siRNA delivery based on polyethylenimine by grafting hydrophilic acrylamide segments and hydrophobic poly(γ-benzyl L-glutamate). The amphiphilic PEI-PBLG/siRNA complex demonstrates high gene silencing efficiency in the absence or presence of 10 vol% and 50 vol% sera in vitro. The anti-tumor effects in vivo are evaluated in luciferase-bearing mice expressing CT26 tumors. PEI-PBLG/siVEGF complex provides a higher and more sustained suppressive effect by reducing VEGF mRNA expression in the tumors, leading to higher tumor growth inhibition efficacy. Further studies on the potential use of the PEI-PBLG carrier system in mediating the silencing of genes other than VEGF or in other tumor models are recommended.
Keywords:
RNA; amphiphiles; anti-tumor; gene therapy; hydrophilic polymers.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Line, Tumor
-
Cell Proliferation / drug effects*
-
Gene Expression Regulation, Neoplastic / drug effects
-
Gene Silencing
-
Genetic Therapy
-
Humans
-
Hydrophobic and Hydrophilic Interactions
-
Mice
-
Polyethyleneimine / administration & dosage
-
Polyethyleneimine / analogs & derivatives*
-
Polyethyleneimine / chemistry
-
Polyglutamic Acid / administration & dosage
-
Polyglutamic Acid / analogs & derivatives*
-
Polyglutamic Acid / chemistry
-
Polymers / administration & dosage
-
Polymers / chemistry
-
RNA, Messenger / biosynthesis
-
RNA, Small Interfering / administration & dosage*
-
RNA, Small Interfering / chemistry
-
RNA, Small Interfering / genetics
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vascular Endothelial Growth Factor A / biosynthesis
-
Vascular Endothelial Growth Factor A / genetics*
Substances
-
Polymers
-
RNA, Messenger
-
RNA, Small Interfering
-
Vascular Endothelial Growth Factor A
-
polyethylenimine-poly(gamma-benzylglutamate)
-
Polyglutamic Acid
-
Polyethyleneimine